<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kang DO</submitter><funding>Korea University Grant</funding><funding>National Research Foundation of Korea (NRF)</funding><funding>National Research Foundation of Korea</funding><pagination>9391</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11920199</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Drug-coated balloon (DCB) treatment is an emerging strategy for de novo coronary artery disease (CAD), but procedural optimization remains uncertain. This study analyzed 317 patients who underwent DCB-based intervention for de novo CAD and angiographic follow-up: SR (successful, stent-like result: diameter stenosis &lt; 20% at follow-up angiography, n = 84, 93 lesions) and Non-SR (n = 224, 358 lesions) groups. Baseline clinical and lesion characteristics were similar, except that SR lesions had larger diameter. In SR lesions, specialty balloons were more frequently utilized (p = 0.025), and maximal balloon diameter and balloon-to-artery ratio were significantly greater compared to Non-SR lesions (p &lt; 0.001 and p = 0.008). At a median 8-month follow-up, SR lesions exhibited larger minimal lumi</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Predictors of optimal angiographic lesion outcomes in drug-coated balloon treatment for de novo coronary artery disease.</pubmed_title><pmcid>PMC11920199</pmcid><funding_grant_id>NRF-2021R1F1A1061337</funding_grant_id><funding_grant_id>RS-2023-00210960</funding_grant_id><funding_grant_id>K2225581</funding_grant_id><funding_grant_id>K1923481, K2022971, K2111151, and K2211921</funding_grant_id><pubmed_authors>Lee JS</pubmed_authors><pubmed_authors>Song WH</pubmed_authors><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Kim B</pubmed_authors><pubmed_authors>Kim SH</pubmed_authors><pubmed_authors>Her AY</pubmed_authors><pubmed_authors>Shin ES</pubmed_authors><pubmed_authors>Kim YH</pubmed_authors><pubmed_authors>Ahn JC</pubmed_authors><pubmed_authors>Kang DO</pubmed_authors><pubmed_authors>Lim SY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predictors of optimal angiographic lesion outcomes in drug-coated balloon treatment for de novo coronary artery disease.</name><description>Drug-coated balloon (DCB) treatment is an emerging strategy for de novo coronary artery disease (CAD), but procedural optimization remains uncertain. This study analyzed 317 patients who underwent DCB-based intervention for de novo CAD and angiographic follow-up: SR (successful, stent-like result: diameter stenosis &lt; 20% at follow-up angiography, n = 84, 93 lesions) and Non-SR (n = 224, 358 lesions) groups. Baseline clinical and lesion characteristics were similar, except that SR lesions had larger diameter. In SR lesions, specialty balloons were more frequently utilized (p = 0.025), and maximal balloon diameter and balloon-to-artery ratio were significantly greater compared to Non-SR lesions (p &lt; 0.001 and p = 0.008). At a median 8-month follow-up, SR lesions exhibited larger minimal lumi</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-07-15T08:28:12.969Z</modification><creation>2025-04-03T23:26:25.007Z</creation></dates><accession>S-EPMC11920199</accession><cross_references><pubmed>40102457</pubmed><doi>10.1038/s41598-025-92052-2</doi></cross_references></HashMap>